1,310 FDA adverse event reports
HYDROQUINONE is manufactured by Obagi Cosmeceuticals LLC and is tracked in the FDA Adverse Event Reporting System (FAERS). There are 1,310 adverse event reports for HYDROQUINONE in the FDA database.
This page focuses specifically on HYDROQUINONE as manufactured by Obagi Cosmeceuticals LLC, providing safety context within the manufacturer's broader drug portfolio. Different manufacturers of the same active ingredient may have different adverse event profiles due to variations in formulation, inactive ingredients, manufacturing processes, and patient populations.
The following adverse reactions have been most frequently reported for HYDROQUINONE manufactured by Obagi Cosmeceuticals LLC:
Out of 559 classified reports for HYDROQUINONE:
The most commonly reported side effects of HYDROQUINONE include SQUAMOUS CELL CARCINOMA OF SKIN, FATIGUE, DRUG INEFFECTIVE. These are based on 1,310 FDA adverse event reports.
HYDROQUINONE has a safety score of N/A based on AI analysis of FDA adverse event reports. Always discuss medication risks with your healthcare provider.